Science Explorer Back to mapMap

Most cited papers from Cystic Fibrosis Research Foundation

What are the most cited papers from Cystic Fibrosis Research Foundation?

The most cited paper from Cystic Fibrosis Research Foundation is "Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report" (Philip M. Farrell, Beryl J. Rosenstein, Terry B. White et al., 2008), with 1,098 citations. Next come "Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa" (961) and "Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference" (800).

Showing 50 of 61 papers. Every paper with more than 96 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report Philip M. Farrell, Beryl J. Rosenstein, Terry B. White et al. · The Journal of Pediatrics Open access 17 Jul 2008 1,098
2 Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa Lisa M. Saiman, Bruce C. Marshall, Nicole Mayer-Hamblett et al. · JAMA 30 Sep 2003 961
3 Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference David A. Stevens, Richard B. Moss, Viswanath P. Kurup et al. · Clinical Infectious Diseases Open access 19 Sep 2003 800
4 ECFS best practice guidelines: the 2018 revision Carlo Castellani et al. · Journal of Cystic Fibrosis Open access Mar 2018 774
5 Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice Carlo Castellani et al. · Journal of Cystic Fibrosis Open access May 2008 598
6 Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition Alessandro Bassi Luciani, Valeria Rachela Villella, Speranza Esposito et al. · Nature Cell Biology 15 Aug 2010 465
7 Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis Peter Garred, Tacjana Pressler, HANS OLE MADSEN et al. · Journal of Clinical Investigation Open access 15 Aug 1999 441
8 Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect Valeria Rachela Villella, Speranza Esposito, Emanuela M. Bruscia et al. · Frontiers in Pharmacology Open access 2013 388
9 Differentiated structure and function of cultures from human tracheal epithelium Mutsuo Yamaya, Walter E. Finkbeiner, Susan Chun et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology Jun 1992 367
10 Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial Eitan Kerem et al. · The Lancet Respiratory Medicine Open access 15 May 2014 346
11 Clinical, Immunological, and Molecular Analysis in a Large Cohort of Patients with X-Linked Agammaglobulinemia: An Italian Multicenter Study Alessandro Plebani et al. · Clinical Immunology Sep 2002 329
12 Heparan Sulfate Glycosaminoglycans Are Involved in Adenovirus Type 5 and 2-Host Cell Interactions Maria Cristina Dechecchi, Anna Tamanini, Alberto Bonizzato et al. · Virology Open access Mar 2000 265
13 Is liver fibrosis reversible? R. Christopher Benyon, J P IREDALE · Gut Open access Apr 2000 264
14 Cystic fibrosis: a clinical view Carlo Castellani, Baroukh Maurice Assael · Cellular and Molecular Life Sciences Open access 5 Oct 2016 260
15 Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts Eleonora Cremonini, Emanuele Zonaro, Marta Donini et al. · Microbial Biotechnology Open access 20 Jun 2016 260
16 A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis Heiko Witt et al. · Nature Genetics Open access 14 May 2006 252
17 Guidelines for the management of pregnancy in women with cystic fibrosis Frank Peter Edenborough, Graziella Borgo, Christiane Knoop et al. · Journal of Cystic Fibrosis Open access 27 Nov 2007 248
18 European best practice guidelines for cystic fibrosis neonatal screening Carlo Castellani et al. · Journal of Cystic Fibrosis Open access 27 Feb 2009 246
19 Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders – updated European recommendations Els Dequeker, Manfred Stuhrmann, Michael A. Morris et al. · European Journal of Human Genetics Open access 6 Aug 2008 245
20 Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study Gianni Mastella, Maurizio Rainisio, Hinrich Karsten Harms et al. · European Respiratory Journal Open access Sep 2000 245
21 Draft consensus guidelines for diagnosis and treatment of Shwachman‐Diamond syndrome Yigal Dror, Jean Donadieu, Jutta Köglmeier et al. · Annals of the New York Academy of Sciences Dec 2011 243
22 Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov. Enrico Tortoli, Thomas Andreas Kohl, Barbara A. Brown‐Elliott et al. · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY Open access 7 Aug 2016 242
23 Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: Inconsistent correlation between forkhead box protein 3 expression and disease severity Eleonora Gambineri et al. · Journal of Allergy and Clinical Immunology Open access 26 Oct 2008 226
24 Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome) Melanie M. Hagleitner et al. · Journal of Medical Genetics 24 Sep 2007 220
25 Presence of cystic fibrosis‐related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic Fibrosis Christian Koch, Maurizio Rainisio, U. Madessani et al. · Pediatric Pulmonology 9 Oct 2001 218
26 European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations Christian Koch, H. Cuppens, Maurizio Rainisio et al. · Pediatric Pulmonology 2001 198
27 Mutations of DNAI1 in Primary Ciliary Dyskinesia Maimoona A. Zariwala et al. · American Journal of Respiratory and Critical Care Medicine Open access 20 Jul 2006 188
28 Sulfatides trigger increase of cytosolic free calcium and enhanced expression of tumor necrosis factor-alpha and interleukin-8 mRNA in human neutrophils. Evidence for a role of L-selectin as a signaling molecule. Carlo Laudanna, Gabriela Constantin, Pierluigi Baron et al. · Journal of Biological Chemistry Open access Feb 1994 185
29 Early eradication therapy againstPseudomonas aeruginosain cystic fibrosis patients Giovanni Taccetti, Sara Campana, Filippo Festini et al. · European Respiratory Journal Open access 31 Aug 2005 181
30 Swelling-induced and depolarization-induced C1-channels in normal and cystic fibrosis epithelial cells C. K. Solc, Jeffrey J. Wine · American Journal of Physiology-Cell Physiology Oct 1991 167
31 Newborn screening for cystic fibrosis Carlo Castellani, John Massie, Marci K. Sontag et al. · The Lancet Respiratory Medicine 3 Apr 2016 161
32 Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: A pilot study Eugenia Bruzzese, Valeria Raia, Maria Immacolata Spagnuolo et al. · Clinical Nutrition 14 Mar 2007 160
33 Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling Luis Felipe Reyes et al. · American Journal of Respiratory and Critical Care Medicine Open access 14 Jun 2017 153
34 CFTR in Calu-3 human airway cells: channel properties and role in cAMP-activated Cl- conductance Christine M. Haws, Walter E. Finkbeiner, Jonathan H. Widdicombe et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology May 1994 149
35 A Functional Anatomic Defect of the Cystic Fibrosis Airway Susan E. Birket, Kengyeh K. Chu, Linbo Liu et al. · American Journal of Respiratory and Critical Care Medicine Open access 16 Jul 2014 148
36 Celiac disease and obesity: need for nutritional follow-up after diagnosis Enrico A. Valletta, M. Fornaro, Marco Cipolli et al. · European Journal of Clinical Nutrition 18 Aug 2010 147
37 Chloride conductance and genetic background modulate the cystic fibrosis phenotype of ΔF508 homozygous twins and siblings Inez Bronsveld, Frauke Mekus, Jan Bijman et al. · Journal of Clinical Investigation Open access Dec 2001 146
38 Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial Baroukh Maurice Assael, Tacjana Pressler, Diana Bilton et al. · Journal of Cystic Fibrosis Open access 15 Sep 2012 138
39 Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype Mariantonietta Cicoira, Luisa Zanolla, Andrea da Silveira Rossi et al. · Journal of the American College of Cardiology Open access Jun 2001 138
40 IL-4 Is a Potent Modulator of Ion Transport in the Human Bronchial Epithelium In Vitro Luis J. V. Galietta, Patrick Pagésy, Chiara Folli et al. · The Journal of Immunology Open access 2002 137
41 Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide Marianne Skov, Katharina Maria Main, Sillesen Ib et al. · European Respiratory Journal Open access Jul 2002 136
42 New clinical diagnostic procedures for cystic fibrosis in Europe K. De Boeck, Nico Derichs, Isabelle Fajac et al. · Journal of Cystic Fibrosis Open access Jun 2011 128
43 A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis Sarah J. Mayell, À. Munck, Jean V Craig et al. · Journal of Cystic Fibrosis Open access 29 Oct 2008 127
44 Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo F. John McLaughlin, Wallace J. Matthews, Denise J. Strieder et al. · The Journal of Infectious Diseases Mar 1983 125
45 Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Peter R. Durie, Louis M. Bell, W Linton et al. · Gut Open access Sep 1980 119
46 Tissue Transglutaminase Activation Modulates Inflammation in Cystic Fibrosis via PPARγ Down-Regulation Luigi Maiuri, Alessandro Bassi Luciani, Ida Giardino et al. · The Journal of Immunology Jun 2008 118
47 Azithromycin Selectively Reduces Tumor Necrosis Factor Alpha Levels in Cystic Fibrosis Airway Epithelial Cells Cristina Cigana, Baroukh Maurice Assael, Paola Melotti · Antimicrobial Agents and Chemotherapy Open access 9 Jan 2007 117
48 CFTR channels in immortalized human airway cells Christine M. Haws, Mauri E. Krouse, Yifan Xia et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology Dec 1992 112
49 Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease Massimo Conese, Elena Copreni, Sante Di Gioia et al. · Journal of Cystic Fibrosis Open access 16 Jul 2003 111
50 BMD and Body Composition in Children and Young Patients Affected by Cystic Fibrosis Maria Luisa Bianchi, Giovanna Romano, Silvia Saraifoger et al. · Journal of Bone and Mineral Research Mar 2006 106

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.